Parkinson's Disease Registry of the Muhammad Ali Parkinson Center

NCT00217321 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2010-07-21

No results posted yet for this study

Summary

The purpose of the Parkinson's disease Registry is to develop a national and international database of persons with Parkinson's disease (PD). The Registry will be used to facilitate the development of new therapies and healthcare services to improve the quality of life for people with PD. It will also be a means for investigators in the field of PD to quickly identify and notify subjects about other research studies for which they are eligible.

Objectives include:

* Assess current treatment approaches and develop best-practice guidelines
* Track the functional abilities, access to healthcare and cost of illness of people with PD over time
* Drive the development of innovative research projects
* Accelerate the process of informing patients of research projects for which they may be eligible

Conditions

Sponsors & Collaborators

  • Barrow Neurological Foundation

    collaborator OTHER
  • Muhammad Ali Parkinson Research Center

    lead OTHER

Principal Investigators

  • Abraham Lieberman, MD · MAPC

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00217321 on ClinicalTrials.gov